Kromek selected for UK Government Framework

Kromek Group PLC

30 July 2024

 

30 July 2024

Kromek Group plc

("Kromek" or the "Group")

Kromek selected for UK Government Resilience Framework

First order received under the framework from Merseyside Fire & Rescue Service

Kromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that its D3M detector has been named as the Personal Radiation Detector ("PRD") under the UK Government Resilience Framework (the "Framework"). The Group has received its first order under the Framework from Merseyside Fire & Rescue Service, which will use the D3M for its Detection, Identification and Monitoring ("DIM") vehicles.  

The Framework is designed to strengthen the UK's resilience system to prevent risks manifesting or crises happening where possible, addressing all serious threats to public safety and security. It focuses on the foundational building blocks of resilience, setting out a plan to 2030 to strengthen the frameworks, systems and capabilities that underpin the UK's resilience to all civil contingencies risks.  

The D3M is the only PRD that has been pre-approved for purchase under the Framework, which is scheduled to be in place for four years. As a result, all blue light service operators in the UK, such as fire, police, ambulances and first responders, can purchase the D3M detector for projects under the Framework without going through a separate approval process.

Merseyside Fire & Rescue service have bought the D3M under their Detection, Identification and Monitoring (DIM) Equipment Uplift project, which involves acquiring equipment to enhance their capabilities for detection of Chemical, Biological, Radiological, and Nuclear ("CBRN") threats.

Arnab Basu, CEO of Kromek, said: "We are delighted that our D3M detector has been named as the only PRD under this significant UK initiative and to have received our first order from Merseyside Fire & Rescue Service. The D3M is a world-leading radiation detector that offers unprecedented situational awareness. Being selected for this framework is another validation of the strength of our solutions and opens up another important commercial avenue for our CBRN products. We look forward to supporting Merseyside Fire & Rescue Service and other emergency service operators in identifying potential radiological threats and keeping people safe."

For further information, please contact:

Kromek Group plc
Arnab Basu, CEO  Paul Farquhar, CFO	[phone]
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance  Tim Redfern - ECM	[phone]
Michael Johnson/Tamar Cranford-Smith - Sales
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble	[phone]

Kromek Group plc 

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  

The advanced imaging segment comprises the medical, security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defense and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of 'dirty bombs'.  

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  

Further information is available at www.kromek.com. 

 

END